EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Identifying the deficiencies of currently available CGM to improve uptake and benefit

Katharine D Barnard-Kelly, Maria Asunción Martínez-Brocca, Timor Glatzer, Nick Oliver iD

Diabetic Medicine · 2024

DOI: 10.1111/dme.15338 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Katharine D Barnard-Kelly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Spotlight Consultations Ltd, Portsmouth, UK. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Roche Diabetes Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The use of diabetes technologies is increasing worldwide, with health systems facilitating improved access to devices. Continuous glucose monitoring is a complex intervention that provides information on glucose concentration, rate and direction of change, historical data and alerts and alarms for extremes of glucose. These data do not themselves change glycaemia and require translation to a meaningful action for impact. It is, therefore, crucial that such systems advance to better meet the needs of individuals using them.

Methods

Narrative review of the use of, engagement with, limitations and unmet needs of continuous glucose monitoring systems.

Results

CGM devices have made a significant contribution to the self‐management of diabetes; however, challenges with access and user experience persist, with multiple limitations to uptake and benefit. These limitations include physical size and implementation, with associated stigma, alarm fatigue, sleep disturbance and the challenge of addressing large volumes of real‐time data. Greater personalisation throughout the continuous glucose monitoring journey, with a focus on usability, may improve the benefits derived from the device and reduce the burden of self‐management. Healthcare professionals may have unconscious biases that affect the provision of continuous glucose monitors due to deprivation, education, age, ethnicity and other characteristics.

Conclusions

Continuous glucose monitoring exerts a dose‐dependent response; the more it is used, the more effective it is. For optimal use, continuous glucose monitors must not just reduce the burden of management in one dimension but facilitate net improvement in all domains of self‐management for all users.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Glucose Self-MonitoringHumansBlood GlucoseDiabetes MellitusDiabetes Mellitus, Type 1Self-Management

Stichwörter der Autor:innen

continuous blood glucose monitoringdiabetespsychosocial

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Spotlight Consultations Ltd, Portsmouth, UK.
  • Southern Health NHS Foundation Trust, Southampton, UK.
  • Hospital Universitario Virgen Macarena, Seville, Spain.
  • Roche Diabetes Care, Mannheim, Germany.
  • Imperial College, London, UK.

ORCID-Profile: Nick Oliver

Förderung

  • Roche Diabetes Care

Zitieren

APA

Barnard-Kelly, K. D., Martínez-Brocca, M. A., Glatzer, T., & Oliver, N. (2024). Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabetic Medicine. https://doi.org/10.1111/dme.15338

Vancouver

Barnard-Kelly KD, Martínez-Brocca MA, Glatzer T, Oliver N. Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabetic Medicine. 2024. doi:10.1111/dme.15338

BibTeX
@article{BarnardKelly2024,
  author = {Barnard-Kelly, Katharine D and Martínez-Brocca, Maria Asunción and Glatzer, Timor and Oliver, Nick},
  title = {Identifying the deficiencies of currently available CGM to improve uptake and benefit},
  journal = {Diabetic Medicine},
  year = {2024},
  doi = {10.1111/dme.15338}
}
Kostenlos starten →